PROS1 and COVID-19: Due to the binding S protein of SARS-CoV-2 to ACE2 receptor of alveolar type 2 (AT2) lung cells and the lysis of these cells by the virus, it seems reasonable to reduce the synthesis and secrete endogenous surfactant in COVID-19 patients.